Special Report – Veterans and HBOT
The unfortunate truth is that countless veterans, just like Simon, repeatedly battle suicidal thoughts. They struggle from their battle wounds and PTSD with each passing minute.
These brave souls protected our country, and it’s beyond time that we protect their future. Thankfully there is hope in HBOT.
Watch the 30 Minute Special Report
Veterans are at especially high risk for suicide due to the injuries they’ve endured and the horrific images they’ve seen. Post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) rank high among the reasons why veterans are choosing death over living. But there is hope for new beginnings. Hyperbaric oxygen therapy (HBOT) is helping war veterans turn their lives around.
In this Special Report, Edward diGirolamo, host of the HBOT News Network, dives into HBOT and what the state of North Carolina is doing to help get veterans this life saving therapy. We hear from Melissa Spain, CEO of the Community Foundation of NC East, as she discusses their involvement to get NC Senate Bill 442 passed; a bill that has appropriated funds to provide HBOT to NC veterans who suffer from TBI and PTSD.
We are also greeted by Elena Schertz, Nurse Practitioner at Extivita-RTP in Durham, NC. Elena gives us a tour of their state-of-the-art clinic where soldiers are receiving HBOT. One of their veteran patients, Simon LeMay, agreed to share his story with us to help spread the hope that exists within the world of hyperbaric oxygen therapy.
Meet a true American Hero, Simon LeMay, retired Sergeant Major with 25-years in the US Marine Corps. LeMay was deployed to Iraq and Afghanistan five times during a ten year period. He lost his best friend in battle and witnessed horrific incidents of violence and injury among his Marine bothers. Although LeMay was blessed to avoid serious physical injury to himself, he did come home with an invisible wound of war.
IED exposures left him with a TBI and visions of war and death haunted him with PTSD. Simon turned to alcohol and pain pills to ease the emotional and physical pain, leading him down a dark tunnel of depression and suicidal thoughts that almost ended in demise.
After hearing about it from friends, his loving family talked him into trying hyperbaric oxygen therapy to help heal his brain injuries. LeMay received treatment at Extivita- RTP in Durham, NC and states after 20-30 treatments he started realizing that he was once again “starting to feel emotion,” with the sense of worthlessness disappearing and the suicidal ideation being no more.
“I started looking forward to the next day,” Simon exclaims.
Also included in this Special Report is a raw and personal interview with Cate, Simon’s wife. Today she is thrilled with Simon’s progress, even calling hyperbaric oxygen therapy “God sent.”
Subscribe Now, It’s Free!
Recent HBOT News
Clinical Trial – Caudal Block,Saddle Block, Anorectal Surgery
Anorectal surgery includes pilonidal sinus, hemorrhoidectomy, anal fissure, and anal fistula
operations. Various surgical and anesthetic techniques have been used to increase the level
of analgesia in perioperative period and decrease the length of stay in the hospital. In this
study, investigators investigate the effects of routinely applied anesthesia techniques
during anorectal surgery, caudal block and saddle block, on patients’ perioperative
hemodynamic values, sensory and motor block levels, and postoperative pain scores.
Clinical Trial – Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares
Ulcerative colitis (UC) is a chronic inflammatory bowel disease associated with recurrent
mucosal inflammation. Clinically, the disease is characterized by bloody diarrhea, abdominal
pain, and constitutional symptoms such as fever and weight loss. Treatment strategies vary
based on disease activity and target various aspects of the inflammatory cascade. Options
include: anti-inflammatory drugs (mesalamine), immunosuppressive or modulatory medications
(corticosteroids, thiopurines, cyclosporine) and biologic agents (Anti-TNF). Disease severity
can be wide ranging, and nearly 25% of UC patients are hospitalized for acute severe disease.
Of these patients, 30% will undergo colectomy after the acute episode, a quarter of which
will experience post-operative complications. Although there has been great progress in
treatment of UC over the past decade, even with the anti-TNF agent infliximab, the one-year
remission rate for patients not responding to conservative management is barely 20%.
Furthermore, corticosteroids have significant long-term consequences and immune suppressive
drugs such as 6-mercaptopurine, azathioprine and infliximab have been associated with serious
adverse events including life-threatening infections and lymphomas. With growing evidence
that the pathogenesis of UC is multi-factorial and involves a complex interaction of genetic
and environmental factors, newer treatment modalities are being evaluated to target the
mucosal immune response and mucosal inflammatory regulatory system.
Hyperbaric oxygen offers a promising new treatment option since it targets both tissue
hypoxia and inflammation. Recent small scales studies evaluating the impact of hyperbaric
oxygen treatment in acute ulcerative colitis flares demonstrated improved outcomes. The
mechanisms underlying the improvement are not known. In this study, we will treat ulcerative
colitis flares with hyperbaric oxygen and measure changes in both markers of tissue hypoxia
and inflammation. We hypothesize that hyperbaric oxygen will (a) improve outcomes, and (b)
show reductions in markers of both tissue hypoxia and inflammation.
Arizona Legislature Approves Hyperbaric Oxygenation Treatment for Veterans with Traumatic Brain Injury
TUCSON, Ariz., April 02, 2018 (GLOBE NEWSWIRE) -- Veterans with traumatic brain injuries (TBI) and selected post-traumatic stress disorder (PTSD) conditions would be eligible to participate in hyperbaric oxygenation therapy (HBOT) under a bill approved unanimously in...


